Applied DNA Sciences, Inc. (OTCBB: APDN) announces that it has
launched a new, DNA-secured form of the QR ("quick read") code.
digitalDNA™ is a new security tool that utilizes the flexibility of
mobile communications, the instant accessibility of secure,
cloud-based data, and the absolute certainty of DNA to make item
tracking and authentication fast, easy and definitive, while
providing the opportunity to create a new and exciting customer
interface.
The product uses forensic authentication of a botanical DNA
marker, sequence-encrypted within a secure QR code, and physically
included within the ink used to digitally print the code. The
resulting pattern or "rune" can be scanned via an Apple-approved
app with an iPhone to assure originality. These mobile scans can be
performed anywhere along the supply chain without limit.
The scan checks in wirelessly with a secure database in a
"private, secure cloud," and displays the resulting analysis back
on the iPhone screen. Tracking information is fed into "tunable
algorithms" that use pattern recognition to automatically identify
supply-chain risks, for counterfeits or product diversion.
Rapid-reading reporters, associated with the DNA marker, are also
embedded in the ink, and prevent the secure code from being
digitally copied. The uncopyable, botanically-derived DNA markers
included in all digitalDNA codes serve as a forensic backstop in
legal cases where absolute proof of originality is required.
Forensic authentication of the DNA in the ink, must match the
sequences and length polymorphism found in the decrypted digitalDNA
code.
The technology avoids the risks of phishing scams to which
non-secure QR codes are notoriously vulnerable, while providing
authentication, geolocation and time-stamping throughout the supply
chain. The ubiquity of the iPhone platform allows the consumer to
participate in the authentication scheme, quickly and easily. In
addition, end-users could confirm freshness and expiration, connect
to real-time or video technical support, identify local resources,
easily place reorders, and participate in peer-to-peer selling.
The digitalDNA platform is designed to meet compliance
specifications defined by the PCI (Payment Card Industry) Security
Standards Council, the new and strict standards developed for
handling credit card transactions, and HIPAA (Health Insurance
Portability and Accountability Act), the stringent requirements for
protecting personal health information.
The technology evolved from a partnership agreement signed with
secure cloud-computing specialist DivineRune, Inc, on January 25th
of this year. The partnership will enhance and extend APDN's core
anti-counterfeiting, anti-diversion, and security systems into the
digital track-and-trace sphere. The companies jointly described the
agreement as "taking APDN's best-in-class anti-counterfeiting and
authentication systems and marrying them to the best in secure
mobile applications and advanced cloud computing."
Dr. James A. Hayward, President and CEO of APDN, commented that
he sees "a terrific synergy" in the partnership with DivineRune,
whose name derives from a reference to symbology typified by the
rise in applications of QR codes. "Our products today uniquely
offer our customers proven, uncopyable authentication of virtually
any product or asset," he said. "We are now ready to leverage the
expertise of DivineRune to offer enhanced authentication systems
which are faster, even more accessible and innovative. I believe
that you will see some truly imaginative technology emerging from
this partnership."
The DivineRune management team specializes in highly secured IT
systems for companies looking to send and store information in
"private clouds." They boast a track record of success in building
computing systems that operate in the most challenging
environments. "These are areas which are in need of the highest
security available, including advanced encryption of data in
transit and at rest," explained John Paul Pennisi, Product Manager
at DivineRune. "Without doubt, this partnership will reap the
benefits of our core competencies in cloud computing, mobile
devices, and logistics," he said.
digitalDNA can be used to track individually packaged items,
such as drugs or luxury goods, when the space on the item is
available to print the digitalDNA matrix. On items too small for
the matrix, such as microchips, digitalDNA can be used on lot
shipments.
The combined DNA-IT platform will also aim to satisfy
requirements of the California E-Pedigree Law (SB 1307
(Ridley-Thomas, Chapter 713, Statutes of 2008), which requires an
electronic record of every sale of prescription drugs in the state.
The pedigree must thoroughly document the drug, including its
source, identification, and other data. Some features of the law
require compliance as early as 2015. The California law is said by
many to have wide repercussions for the pharmaceutical industry
globally.
APDN is selling digitalDNA directly and through its existing
channel partnerships. An alpha sale was already placed with a
multinational personal care company. Hayward stated: "digitalDNA
could revolutionize supply chain security, and is relevant to all
the industry verticals we currently service. digitalDNA offers
logistic enhancement consistent with Section 818 of the National
Defense Authorization Act, which mandates that defense suppliers
take steps to eliminate counterfeits within their supply chain. A
related product, Our SigNature DNA™ is completing a military pilot
designed to provide Section 818 compliance at the item level, while
digitalDNA facilitates compliance for bulk shipments."
About Applied DNA Sciences
APDN sells patent-protected DNA security solutions to protect
products, brands and intellectual property from counterfeiting and
diversion. SigNature® DNA is a botanical mark used to authenticate
products in a unique manner that essentially cannot be copied, and
provide a forensic chain of evidence that can be used to prosecute
perpetrators. To learn more, go to www.adnas.com where APDN
routinely posts all press releases.
The statements made by APDN may be forward-looking in nature.
Forward-looking statements describe APDN's future plans,
projections, strategies and expectations, and are based on
assumptions and involve a number of risks and uncertainties, many
of which are beyond the control of APDN. Actual results could
differ materially from those projected due to our short operating
history, limited financial resources, limited market acceptance,
market competition and various other factors detailed from time to
time in APDN's SEC reports and filings, including our Annual Report
on Form 10-K, filed on December 8, 2011 and our subsequent
quarterly reports on Form 10-Q. APDN undertakes no obligation to
update publicly any forward-looking statements to reflect new
information, events or circumstances after the date hereof to
reflect the occurrence of unanticipated events.
About DivineRune, Inc.
DivineRune is a cutting-edge software development firm with a
specialty in advanced cloud-based technology solutions for global
organizations. With its deep patent portfolio, DivineRune is the
emerging technology leader in real-time mobile authentication and
fraud detection for secure logistics, counterfeit detection and
tracking, and market diversion in the supply chain. Upon capturing
and aggregating data from various sources, including existing ERP
systems, DivineRune technology performs location-based analytics
and provides a true provenance of products as they ship through the
supply chain. For additional information on DivineRune, please
contact info@divinerune.com.
INVESTOR CONTACT: Debbie Bailey 631-444-8090 fax: 631-444-8848
MEDIA CONTACT: Mitchell Miller 646-543-3373 fax: 631-444-8848 FCMN
Contact: Email Contact Web site: http://www.adnas.com Twitter:
@APDN, @APDNInvestor
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Apr 2024 to May 2024
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From May 2023 to May 2024